Lucie Heinzerling

Lucie Heinzerling

UNVERIFIED PROFILE

Are you Lucie Heinzerling?   Register this Author

Register author
Lucie Heinzerling

Lucie Heinzerling

Publications by authors named "Lucie Heinzerling"

Are you Lucie Heinzerling?   Register this Author

90Publications

2453Reads

5Profile Views

The Role of Immune Checkpoint Blockade in Uveal Melanoma.

Int J Mol Sci 2020 Jan 29;21(3). Epub 2020 Jan 29.

Department of Dermatology, Universitätsklinikum Erlangen, Friedrich Alexander University, Ulmenweg 18, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21030879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037664PMC
January 2020

Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial Tumors.

Facial Plast Surg 2019 Dec 30. Epub 2019 Dec 30.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-3401805DOI Listing
December 2019

Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response.

Rheumatology (Oxford) 2019 10;58(10):1875-1877

Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez164DOI Listing
October 2019

C-reactive protein as an early marker of immune-related adverse events.

J Cancer Res Clin Oncol 2019 Oct 6;145(10):2625-2631. Epub 2019 Sep 6.

Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-019-03002-1
Publisher Site
http://dx.doi.org/10.1007/s00432-019-03002-1DOI Listing
October 2019

Characterization of tanning behavior assessed via online survey: Attitudes, habits, and preventive measures with focus on sunscreen use.

Photodermatol Photoimmunol Photomed 2019 Jul 25;35(4):268-274. Epub 2019 Mar 25.

Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/phpp.12465
Publisher Site
http://dx.doi.org/10.1111/phpp.12465DOI Listing
July 2019

Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry.

J Am Acad Dermatol 2019 May 29;80(5):1299-1307.e7. Epub 2019 Jan 29.

Center for Dermatooncology, Department of Dermatology, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.044DOI Listing
May 2019

In Reply.

Dtsch Arztebl Int 2019 May;116(20):363-364

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2019.0363bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637658PMC
May 2019

Senescence markers: Predictive for response to checkpoint inhibitors.

Int J Cancer 2019 03 4;144(5):1147-1150. Epub 2018 Dec 4.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31763DOI Listing
March 2019

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma.

BMC Cancer 2019 Mar 7;19(1):207. Epub 2019 Mar 7.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5384-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407264PMC
March 2019

c-Rel is a cell cycle modulator in human melanoma cells.

Exp Dermatol 2019 Feb 21;28(2):121-128. Epub 2018 Dec 21.

Department of Dermatology, Venereology and Allergology, Georg-August-University, University Medical Center Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.13848DOI Listing
February 2019

Checkpoint Inhibitors.

Dtsch Arztebl Int 2019 02;116(8):119-126

Department of Dermatology, University Hospital Erlangen-Nürnberg; Department of Internal Medicine II, University Hospital, Ludwig-Maximilians-University (LMU )Munich; Department of Medicine 3, University Hospital Erlangen-Nürnberg; Department of Medicine 1, University Hospital Erlangen-Nürnberg; Clinic for Dermatology, Essen University Hospital, University of Duisburg-Essen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2019.0119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454802PMC
February 2019

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients.

Eur J Cancer 2018 07 26;98:10-16. Epub 2018 May 26.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183081
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.04.010DOI Listing
July 2018

Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients.

Oncotarget 2018 Jun 22;9(48):28903-28909. Epub 2018 Jun 22.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034742PMC
June 2018

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.

Cancer Immunol Immunother 2018 05 27;67(5):825-834. Epub 2018 Feb 27.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-018-2134-zDOI Listing
May 2018

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

J Am Coll Cardiol 2018 04 19;71(16):1755-1764. Epub 2018 Mar 19.

Cardiac MR PET CT Program, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.02.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196725PMC
April 2018

BRAF Inhibitors and Radiation Do Not Act Synergistically to Inhibit WT and V600E BRAF Human Melanoma.

Anticancer Res 2018 03;38(3):1335-1341

Department of Dermatology, University Hospital of Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12356DOI Listing
March 2018

Can checkpoint inhibitor therapy improve response to chemotherapy?

J Cancer Res Clin Oncol 2018 01 24;144(1):183-185. Epub 2017 Nov 24.

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2546-8DOI Listing
January 2018

Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports.

J Immunother Cancer 2018 01 15;6(1). Epub 2018 Jan 15.

Department of Dermatology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0309-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767974PMC
January 2018

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy.

Int J Mol Sci 2018 Jan 18;19(1). Epub 2018 Jan 18.

Department of Dermatology, Universitätsklinikum Erlangen and Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91052 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19010289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796234PMC
January 2018

Interest in tanning beds and sunscreen in German-speaking countries.

J Dtsch Dermatol Ges 2017 Dec 17;15(12):1192-1198. Epub 2017 Nov 17.

Department of Dermatology and Allergology, University Medical Center Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13380DOI Listing
December 2017

Das Interesse an Solarien und Sonnenschutz im deutschsprachigen Raum.

J Dtsch Dermatol Ges 2017 Dec;15(12):1192-1198

Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13380_gDOI Listing
December 2017

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions.

Cancer Treat Rev 2017 Jun 18;57:36-49. Epub 2017 May 18.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.05.003DOI Listing
June 2017

The tanning habits and interest in sunscreen of Google users: what happened in 12 years?

Photodermatol Photoimmunol Photomed 2017 Mar 19;33(2):68-74. Epub 2017 Jan 19.

Department of Dermatology, University Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/phpp.12289
Publisher Site
http://dx.doi.org/10.1111/phpp.12289DOI Listing
March 2017

A review of serious adverse effects under treatment with checkpoint inhibitors.

Curr Opin Oncol 2017 03;29(2):136-144

aDepartment of Dermatology, University Hospital Erlangen, Erlangen, Germany bDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000358DOI Listing
March 2017

The neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry.

Oncotarget 2017 Jan;8(1):1117-1131

Institute of Biochemistry (Emil-Fischer-Center), Friedrich Alexander University Erlangen-Nürnberg, Erlangen, 91054, Germany.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/13585
Publisher Site
http://dx.doi.org/10.18632/oncotarget.13585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352040PMC
January 2017

Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy.

Immunotherapy 2017 01;9(2):115-121

Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0138DOI Listing
January 2017

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Medicine (Baltimore) 2016 Nov;95(46):e5375

aDepartment of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel bInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg, Hamburg cDepartment of Dermatology, Eberhard-Karls University of Tuebingen, Tuebingen dSkin Cancer Center Hannover, Hannover eUniversity of Hamburg, Hamburg fDepartment of Dermatology, University Hospital Erlangen, Erlangen gTABEA Clinic, Hamburg hDepartment of Dermatology, University Hospital Essen, Essen iDepartment of Dermatology, University of Mainz, Mainz jMSD Sharp & Dohme GmbH, Munich kDepartment of Dermatology, University Hospital (UKSH), Campus Lübeck, Luebeck lSkin Cancer Unit, German Cancer Research Center (DKFZ) mDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120927PMC
November 2016

Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma.

Eur J Cancer 2016 09 6;65:182-4. Epub 2016 Aug 6.

Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.07.003DOI Listing
September 2016

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom.

J Dtsch Dermatol Ges 2016 Jul;14(7):662-83

Hauttumorzentrum Hannover, Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13047_gDOI Listing
July 2016

Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma.

J Dtsch Dermatol Ges 2016 Jul;14(7):662-81

Hanover Skin Cancer Center, Department of Dermatology, Venereology, and Allergology, Hanover Medical College, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13047DOI Listing
July 2016

Which melanoma patient carries a BRAF-mutation? A comparison of predictive models.

Oncotarget 2016 Jun;7(24):36130-36137

Department of Dermatology, Center for Dermato Oncology, University Medical Center Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094988PMC
June 2016

Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients.

Dermatology 2015 27;231(2):127-33. Epub 2015 Jun 27.

Department of Dermatology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000381849DOI Listing
May 2016

Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.

PLoS One 2015 26;10(5):e0128370. Epub 2015 May 26.

Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Dermatology, STIs, and Allergy, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128370PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444314PMC
April 2016

Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab.

J Immunother 2015 Jun;38(5):212-5

Departments of *Dermatology ‡Internal Medicine I §Internal Medicine III †Institute of Pathology, University Hospital of Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000081DOI Listing
June 2015

Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy.

Strahlenther Onkol 2014 Nov 26;190(12):1169-72. Epub 2014 Jun 26.

Department of Radiation Oncology University Hospital Erlangen, Universitätsstraße 27, 91054, Erlangen, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-014-0698-xDOI Listing
November 2014

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.

Melanoma Res 2014 Aug;24(4):322-31

aInstitute of Molecular Biology and Biophysics bBioLink Ltd, Novosibirsk cN.N.Blokhin Russian Cancer Research Center, Moscow, Russia dBioron GmbH, Ludwigshafen eInstitute of Pathology fDepartment of Dermatology, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000090DOI Listing
August 2014

Drug-induced dilemma: angiokeratomas and decreased renal function.

Am J Med 2014 Jul 13;127(7):598-600. Epub 2014 Apr 13.

Department of Dermatology, University Hospital Erlangen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2014.03.034DOI Listing
July 2014

Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategies.

J Immunother 2010 Oct;33(8):834-9

Department of Dermatology and Allergies, Cantonal Hospital St Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3181eef779DOI Listing
October 2010

Clinical research in cutaneous T-cell lymphoma moving forward.

Arch Dermatol 2008 Jun;144(6):786-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archderm.144.6.786DOI Listing
June 2008

Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis.

Dermatology 2007 ;215(4):325-30

Department of Dermatology and Allergy, Allergy Centre Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/107627
Publisher Site
http://dx.doi.org/10.1159/000107627DOI Listing
October 2007

Interleukin-2: a potential treatment option for postherpetic neuralgia?

Clin Infect Dis 2006 Dec 8;43(12):e109-10. Epub 2006 Nov 8.

Department of Infectious Diseases and Pulmonary Medicine, Charite University Hospital Berlin, Berlin, 13353, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/509639DOI Listing
December 2006

Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.

J Invest Dermatol 2006 Nov 7;126(11):2525-32. Epub 2006 Sep 7.

Berna Biotech Ltd, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jid.5700529DOI Listing
November 2006

Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.

J Clin Immunol 2006 Jul 17;26(4):347-59. Epub 2006 May 17.

Department of Medical Immunology, Charité - University Hospital, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10875-006-9023-5DOI Listing
July 2006

Sublingual immunotherapy.

J Dtsch Dermatol Ges 2006 May;4(5):428-33; quiz 434-5

Department of Dermatology and Allergy, Allergy Center Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1610-0387.2006.05953.xDOI Listing
May 2006

Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses.

Vaccine 2006 Feb 19;24(9):1389-94. Epub 2005 Sep 19.

Unit for Experimental Immunotherapy, University Hospital of Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2005.09.018DOI Listing
February 2006

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells.

Blood 2005 Oct 16;106(7):2287-94. Epub 2005 Jun 16.

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-11-4558DOI Listing
October 2005

Attitudes of traditional healers towards Western medicine in rural Cameroon.

Trop Doct 2005 Jul;35(3):161-4

Department of Dermatology and Allergy, Charité-Universitätsmedizin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/0049475054620653DOI Listing
July 2005

IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.

Exp Dermatol 2004 Jun;13(6):380-90

Institute of Medical Virology, University of Zurich, Gloriastr., Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0906-6705.2004.00191.xDOI Listing
June 2004

Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.

Exp Dermatol 2002 Jun;11(3):232-40

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0625.2001.110306.xDOI Listing
June 2002

Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.

Eur J Dermatol 2002 Mar-Apr;12(2):194-7

Department of Dermatology, University Hospital Zurich, Gloriastr. 31, CH-8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
April 2002